|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/07/17 Sigma Labs, Inc. POS AM 86:4.9M Action Edgar Fil… Svc/FA |
Document/Exhibit Description Pages Size
1: POS AM Post Effective Amendment No. 1 to S-1 HTML 778K
2: EX-23.1 Exhibit 23.1 Auditor's Consent HTML 26K
3: EX-24.1 Exhibit 24.1 Power of Attorney HTML 30K
10: R1 Document and Entity Information HTML 71K
11: R2 Condensed Balance Sheets (June 30th 2017 HTML 107K
unaudited)
12: R3 Condensed Balance Sheets (June 30th 2017 HTML 48K
unaudited) - Parenthetical
13: R4 Condensed Statement of Operations (June 30th 2017 HTML 79K
unaudited)
14: R5 Consolidated Statements of Shareholders' Equity HTML 111K
15: R6 Condensed Statements of Cash Flows (June 30th 2017 HTML 117K
unaudited)
16: R7 Summary of Significant Accounting Policies HTML 71K
17: R8 Stockholders' Equity HTML 100K
18: R9 Note Receivable HTML 32K
19: R10 Notes Payable HTML 42K
20: R11 Continuing Operations HTML 32K
21: R12 Income Taxes HTML 52K
22: R13 Loss Per Share HTML 52K
23: R14 Furniture and Equipment HTML 37K
24: R15 Intangible Assets HTML 47K
25: R16 Commitments and Contingencies HTML 29K
26: R17 Concentrations HTML 46K
27: R18 Joint Venture HTML 30K
28: R19 Defined Contribution Plan HTML 29K
29: R20 Subsequent Events HTML 43K
30: R21 Summary of Significant Accounting Policies: Nature HTML 34K
of Business (Policies)
31: R22 Summary of Significant Accounting Policies: Basis HTML 31K
of Presentation (Policies)
32: R23 Summary of Significant Accounting Policies: HTML 29K
Reclassification (Policies)
33: R24 Summary of Significant Accounting Policies: Loss HTML 30K
Per Share (Policies)
34: R25 Summary of Significant Accounting Policies: HTML 30K
Property and Equipment (Policies)
35: R26 Summary of Significant Accounting Policies: Fair HTML 46K
Value of Financial Instruments (Policies)
36: R27 Summary of Significant Accounting Policies: Income HTML 33K
Taxes (Policies)
37: R28 Summary of Significant Accounting Policies: HTML 33K
Accounts Receivable and Allowance for Doubtful
Accounts (Policies)
38: R29 Summary of Significant Accounting Policies: HTML 29K
Long-Lived and Intangible Assets (Policies)
39: R30 Summary of Significant Accounting Policies: HTML 31K
Recently Enacted Accounting Standards (Policies)
40: R31 Summary of Significant Accounting Policies: Cash HTML 30K
Equivalents (Policies)
41: R32 Summary of Significant Accounting Policies: HTML 30K
Concentration of Credit Risk (Policies)
42: R33 Summary of Significant Accounting Policies: HTML 28K
Organization Expenditures (Policies)
43: R34 Summary of Significant Accounting Policies: Stock HTML 31K
Based Compensation (Policies)
44: R35 Summary of Significant Accounting Policies: HTML 29K
Amortization (Policies)
45: R36 Summary of Significant Accounting Policies: HTML 31K
Accounting Estimates (Policies)
46: R37 Summary of Significant Accounting Policies: HTML 31K
Revenue Recognition (Policies)
47: R38 Summary of Significant Accounting Policies: HTML 29K
Deferred Stock Offering Costs (Policies)
48: R39 Summary of Significant Accounting Policies: HTML 30K
nventory (Policies)
49: R40 Summary of Significant Accounting Policies: HTML 29K
Research and Development (Policies)
50: R41 Summary of Significant Accounting Policies: Fair HTML 35K
Value of Financial Instruments: Schedule of Fair
Value of Financial Instruments (Tables)
51: R42 Summary of Significant Accounting Policies: Fair HTML 32K
Value of Financial Instruments: Schedule of Fair
Value of Derivative Liability (Tables)
52: R43 Stockholders' Equity: Fair Value Measurements, HTML 32K
Recurring and Nonrecurring, Valuation Techniques
(Tables)
53: R44 Stockholders' Equity: Schedule of Fair Value HTML 35K
Assumptions (Tables)
54: R45 Stockholders' Equity: Schedule of Option Activity HTML 60K
(Tables)
55: R46 Income Taxes: Schedule of Deferred Tax Assets and HTML 38K
Liabilities (Tables)
56: R47 Income Taxes: Schedule of Reconciliation of HTML 39K
Provision for Income Taxes (Tables)
57: R48 Loss Per Share: Schedule of Earnings Per Share, HTML 51K
Basic and Diluted (Tables)
58: R49 Furniture and Equipment: Public Utility Property, HTML 36K
Plant, and Equipment (Tables)
59: R50 Intangible Assets: Schedule of Intangible Assets HTML 39K
and Goodwill (Tables)
60: R51 Intangible Assets: Finite-lived Intangible Assets HTML 33K
Amortization Expense (Tables)
61: R52 Concentrations: Schedule of Concentration Risk - HTML 35K
Revenues (Tables)
62: R53 Concentrations: Schedule of Concentration Risk - HTML 37K
Accounts Receivable (Tables)
63: R54 Summary of Significant Accounting Policies: Nature HTML 32K
of Business (Details)
64: R55 Summary of Significant Accounting Policies: Fair HTML 30K
Value of Financial Instruments: Schedule of Fair
Value of Financial Instruments (Details)
65: R56 Summary of Significant Accounting Policies: Fair HTML 30K
Value of Financial Instruments: Schedule of Fair
Value of Derivative Liability (Details)
66: R57 Stockholders' Equity: Fair Value Measurements, HTML 42K
Recurring and Nonrecurring, Valuation Techniques
(Details)
67: R58 Stockholders' Equity (Details) HTML 111K
68: R59 Stockholders' Equity: Schedule of Fair Value HTML 37K
Assumptions (Details)
69: R60 Stockholders' Equity: Schedule of Option Activity HTML 64K
(Details)
70: R61 Note Receivable (Details) HTML 28K
71: R62 Notes Payable (Details) HTML 52K
72: R63 Income Taxes: Schedule of Deferred Tax Assets and HTML 34K
Liabilities (Details)
73: R64 Income Taxes: Schedule of Reconciliation of HTML 35K
Provision for Income Taxes (Details)
74: R65 Loss Per Share: Schedule of Earnings Per Share, HTML 33K
Basic and Diluted (Details)
75: R66 Furniture and Equipment: Public Utility Property, HTML 31K
Plant, and Equipment (Details)
76: R67 Intangible Assets: Schedule of Intangible Assets HTML 35K
and Goodwill (Details)
77: R68 Intangible Assets: Finite-lived Intangible Assets HTML 34K
Amortization Expense (Details)
78: R69 Commitments and Contingencies (Details) HTML 30K
79: R70 Concentrations: Schedule of Concentration Risk - HTML 34K
Revenues (Details)
80: R71 Concentrations: Schedule of Concentration Risk - HTML 36K
Accounts Receivable (Details)
81: R72 Joint Venture (Details) HTML 28K
82: R73 Defined Contribution Plan (Details) HTML 28K
83: R74 Subsequent Events (Details) HTML 49K
85: XML IDEA XML File -- Filing Summary XML 172K
84: EXCEL IDEA Workbook of Financial Reports XLSX 74K
6: EX-101.INS XBRL Instance -- sglb-20170630 XML 968K
4: EX-101.CAL XBRL Calculations -- sglb-20170630_cal XML 103K
5: EX-101.DEF XBRL Definitions -- sglb-20170630_def XML 273K
7: EX-101.LAB XBRL Labels -- sglb-20170630_lab XML 667K
8: EX-101.PRE XBRL Presentations -- sglb-20170630_pre XML 550K
9: EX-101.SCH XBRL Schema -- sglb-20170630 XSD 181K
86: ZIP XBRL Zipped Folder -- 0001078782-17-001502-xbrl Zip 95K
| Exhibit 24.1 Power of Attorney |
Exhibit 24.1
KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below constitutes and appoints John Rice and Nannette Toups and each of them, his or her true and lawful attorneys-in-fact and agents with full power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign Post-Effective Amendment No. 1 to the Form S-1 Registration Statement of Sigma Labs, Inc., Registration No. 333-212735, and any and all amendments to such Post-Effective Amendment No. 1, and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his or her or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Signature | Title | Date |
|
|
|
/s/ John Rice | Interim Chief Executive Officer and Chairman of the Board (Principal Executive Officer) | |
|
|
|
/s/ Nannette Toups | Chief Financial Officer, Treasurer and Secretary (Principal Accounting Officer and Principal Financial Officer) | |
|
|
|
Director | ||
|
|
|
Director | ||
|
|
|
/s/ Dennis Duitch | Director |
| This ‘POS AM’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/7/17 | None on these Dates | ||
| List all Filings | ||||